FDA Approves Medtronic’s Disposable CGM
Drug Topics
AUGUST 14, 2024
Medtronic also announced it has entered a global partnership with Abbott in an effort to expand CGM device options for patients living with diabetes.
Wed.Aug 14, 2024
394 
Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope.
PharmaVoice
AUGUST 14, 2024
The German biotech is leveraging its mRNA platforms to develop a new class of cancer treatments that are necessary to lift the company’s flagging sales.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Hidradenitis Suppurativa Treatment Shows Positive Results in Phase 3 Trial
Drug Topics
AUGUST 14, 2024
Izokibep from Affibody is a small therapeutic protein designed to inhibit IL-17A.
WHO declares mpox outbreak a global health emergency
STAT
AUGUST 14, 2024
The World Health Organization on Wednesday declared the spread of mpox in multiple African countries a public health emergency of international concern, the second such declaration in the past two years called in response to transmission of the virus. The latest decision came on the recommendation of a panel of experts convened to advise WHO Director-General Tedros Adhanom Ghebreyesus on the issue.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Q&A: An Independent Pharmacist’s Hopes for PBM Reform
Drug Topics
AUGUST 14, 2024
Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, talked about current movement toward PBM reform and his hopes for the future of pharmacy.
Opinion: Better safety studies could restore America’s confidence in vaccines
STAT
AUGUST 14, 2024
In February 2021, I received my second Covid-19 shot — the newly developed vaccine that would eventually save millions of lives worldwide — with great anticipation. It proved to be a life-changing event: Two hours later as I was driving home, the shock of a sudden loud and high-pitched whistling nearly caused me to veer off the road. It was as if an audible dog whistle began blaring right next to me.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
STAT+: Sudden cardiac arrest requires luck to survive. Scientists hope to turn those odds around
STAT
AUGUST 14, 2024
By definition, sudden cardiac arrest seems to come out of nowhere. The most shocking cases are when young athletes collapse on the field, but this type of calamity also strikes dedicated middle-age runners, retirees whose health problems seemed well under control, adults of all ages and class. If the person is lucky, medical help is close enough to get the heart beating again after it stops and before brain damage sets in, and the search for the hidden cause can begin.
Mark Cuban wants to keep shaking up healthcare. Here's Cost Plus Drug's next move
Fierce Healthcare
AUGUST 14, 2024
Entrepreneur and investor Mark Cuban wants to "f--k up" the U.S. healthcare system to make it more affordable, the billionaire told "The Daily Show" host Jon Stewart this week. | Entrepreneur and investor Mark Cuban wants to "f--k up" the U.S. healthcare system to make it more affordable, the billionaire told "The Daily Show" host Jon Stewart this week.
Opinion: Ultra-processed foods: the tobacco of the 21st century?
STAT
AUGUST 14, 2024
At the start of the clinic where I see patients with colorectal, stomach, pancreatic, and other gastrointestinal cancers, I remarked to a colleague, “Every new patient on my schedule is under 45.” She replied, “Three of mine are … this is too many young people with cancer.” We felt as though we were in the trenches and didn’t know where the bullets were coming from.
Pharmacists Can Suggest B Vitamin Intake to Treat Parkinson Disease
Pharmacy Times
AUGUST 14, 2024
Individuals with Parkinson disease reported a decrease in bacterial genes for biosynthesis of riboflavin (vitamin B2) and biotin (vitamin B7).
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: Eli Lilly’s billions: Can the world’s most valuable pharma company keep inventing drugs at this pace?
STAT
AUGUST 14, 2024
On Tuesday, Eli Lilly unveiled a towering 346,000-square-foot laboratory in Boston’s Seaport District, a building that will house 500 of the company’s scientists — 300 of whom are still to be hired — who will focus on medicines that work by exploiting the basic mechanisms of human genetics. Another 200 people will be part of companies Lilly will incubate.
Elevating Stroke Care: A Pharmacy Perspective on Telestroke Services
Pharmacy Times
AUGUST 14, 2024
In recent years, telestroke services have transformed stroke care delivery, especially in rural or underserved areas.
Fair Square Medicare rolls out AI voice agents to help enroll seniors into insurance plans
Fierce Healthcare
AUGUST 14, 2024
Getting seniors enrolled into the right Medicare plan is typically an inefficient process that many older patients find confusing and frustrating, spending hours on the phone with human call center | Startup Fair Square Medicare is using advancements with generative AI to build AI-based voice agents to screen seniors for Medicare coverage and improve the customer experience.
FDA Grants Seladelpar Accelerated Approval for Primary Biliary Cholangitis
Pharmacy Times
AUGUST 14, 2024
The decision is based on clinical findings demonstrating seladelpar’s ability to effectively regulate of alkaline phosphatase values in patients.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Kaiser Permanente rolls out Abridge's gen AI clinical tech across 40-hospital system
Fierce Healthcare
AUGUST 14, 2024
Startup Abridge has notched it's largest partnership to date as Kaiser Permanente is making its generative AI tools for medical documentation available to more than 24,000 doctors across its system | Startup Abridge has notched it's largest partnership to date as Kaiser Permanente is making its generative AI tools for medical documentation available to more than 24,000 doctors across its system.
Study Supports Bendamustine-Rituximab as Standard-of-Care in Patients With Indolent Non-Hodgkin Lymphoma
Pharmacy Times
AUGUST 14, 2024
The data builds off prior studies supporting bendamustine-rituximab as a first-line treatment for patients with non-Hodgkin lymphoma.
What the data says about the telehealth market
Fierce Healthcare
AUGUST 14, 2024
In this week's episode of "Podnosis," we’re discussing the challenges and opportunities for telehealth, given some notable setbacks for the industry in recent months. | In this week's episode of "Podnosis," we’re discussing the challenges and opportunities for telehealth, given some notable setbacks for the industry in recent months.
ALS patient lived with a brain-computer interface for 7 years. Here’s what researchers learned
STAT
AUGUST 14, 2024
Brain-computer interfaces are still years, and several FDA approvals, away from being available on the market. Even though industry leaders tout their eventual use for the general public , the first users of these technologies have been and will continue to be people with disabilities. One of the primary uses for BCIs is to provide better communication for people who have been paralyzed.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Insurers push 'food is medicine' interventions but rarely weigh in on ultra-processed food
Fierce Healthcare
AUGUST 14, 2024
Cancer. Heart disease. Mental health disorders. Cognitive impairment. Stroke. Diabetes. | Evidence points to overconsumption of ultra-processed foods leading to severe health outcomes, but food is medicine interventions with insurers rarely set out to directly restrict or limit these foods from their members' diets.
STAT+: Gilead wins U.S. approval for drug to treat autoimmune liver disease
STAT
AUGUST 14, 2024
The Food and Drug Administration on Wednesday approved a new treatment for primary biliary cholangitis, an autoimmune liver disease mainly affecting women that causes decreased liver function, debilitating itching, and fatigue. The drug, called Livdelzi, will be sold by Gilead Sciences, following the $4.3 billion acquisition of CymaBay Therapeutics, its developer, earlier this year.
With FDA approval of Livdelzi, Gilead launches an inflammatory drug for the first time
Fierce Pharma
AUGUST 14, 2024
With an FDA appro | The FDA has approved Gilead's primary biliary cholangitis treatment Livdelzi. The drug, which was acquired in a $4.3 billion buyout of CymaBay Therapeutics six months ago, is the first inflammatory treatment launched by Gilead.
Longevity: Anti-ageing drugs, watch out, here we come…
pharmaphorum
AUGUST 14, 2024
Recent advancements in multi-omics, artificial intelligence (AI), deep learning (DL), ageing biomarkers, precision imaging, ageing clocks, robotics, and smart technologies have empowered researchers to pinpoint common pathways amenable to drug manipulation, with encouraging data now surfacing in early human clinical trials.
J&J and Roche are the strongest companies in the biopharma industry, says S&P Global
Fierce Pharma
AUGUST 14, 2024
Johnson & Johnson and Roche are at the top of S&P Global’s pharmaceutical industry power ratings, which assess the strength of the world’s top 17 drugmakers. | Johnson & Johnson and Roche are at the top of S&P Global’s pharmaceutical industry power ratings, which assess the strength of the world’s top 17 drugmakers.
Completing a successful tech transfer
pharmaphorum
AUGUST 14, 2024
CDMOs like Lannett play a critical role in tackling tech transfer challenges in the pharmaceutical industry. Learn how they navigate diverse challenges to ensure successful transfers.
Health and Wellness Innovation Can Take Many Forms
Pharmacy Times
AUGUST 14, 2024
Roszak highlighted pharmacy data interoperability and food is medicine programs as 2 examples of innovative projects at the National Association of Chain Drug Stores.
Otsuka, Click's depression DTx launches in the US
pharmaphorum
AUGUST 14, 2024
Otsuka and Click Therapeutics' first-in-class prescription digital therapeutic for depression launches in US through mobile app stores
Pharma Pulse 8/14/24: Brands Love Influencers.Until Politics Get Involved, Improving Pain Self-Management Among Rural, Older Cancer Patients & more
Pharmaceutical Commerce
AUGUST 14, 2024
The latest news for pharma industry insiders.
Baxter slims down again, selling kidney division to Carlyle
pharmaphorum
AUGUST 14, 2024
Baxter International has agreed to sell its kidney treatment division to private equity firm Carlyle Group in a $3.8 billion cash deal, continuing its efforts to streamline its operations and reduce debt.
Complying with the DSCSA
Pharmaceutical Commerce
AUGUST 14, 2024
In this part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ Senior Director of DSCSA/Serialization Compliance Services, describes the outcome of the joint public meeting held by the Partnership for DSCSA Governance and the FDA.
AI medtech specialist Firefly lists on Nasdaq after merger
pharmaphorum
AUGUST 14, 2024
Firefly Neuroscience lists on Nasdaq via a $45m merger with IT firm WaveDancer, as it rolls out an AI-powered platform for managing brain function.
Syros shares battered after it stops leukemia trial
STAT
AUGUST 14, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I have learned that a local brewery has been fined by the Illinois Liquor Control Commission for selling cicada-infused malört. A sobering sign that summer is coming to an end.
AZ gets landmark approval for Imfinzi/Lynparza combo
pharmaphorum
AUGUST 14, 2024
AstraZeneca has claimed the first regulatory approval for an immunotherapy/PARP inhibitor combination for endometrial cancer.
Blow to AstraZeneca vaccine project as Reeves plans funding cuts
The Guardian - Pharmaceutical Industry
AUGUST 14, 2024
Chancellor reportedly seeking to cut £20m from the £65m promised by Hunt to Merseyside manufacturing plant Business live – latest updates A £450m plan to expand an AstraZeneca vaccine-manufacturing site in Merseyside has suffered a blow after it emerged the government plans to cut some of the funding for the scheme. It is understood the chancellor, Rachel Reeves, is considering reducing the state aid earmarked for the scheme by more than £20m after her predecessor, Jeremy Hunt, had promised the
Let's personalize your content